Cresco Labs (CRLBF) Net Margin (2020 - 2026)

Cresco Labs (CRLBF) posted Net Margin of 8.77% for Q1 2026, up 83.4% on a QoQ basis from 52.83% in Q4 2025, and down 6.0% year-over-year from 9.33% in Q1 2025.

Cresco Labs (CRLBF) Net Margin (2020 - 2026) Analysis & Trends

Cresco Labs' Net Margin history runs 7 years deep, the most recent figure standing at 8.77% for Q1 2026.

  • Quarterly Net Margin fell 6.0% year-over-year to 8.77% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20.62% (down 1016.0% YoY) and the FY2025 annual result came in at 21.35%, down 1300.0% from the prior year.
  • Net Margin was 8.77% for Q1 2026 at Cresco Labs, up from 52.83% in the prior quarter.
  • Across five years, Net Margin topped out at 3.22% in Q4 2024 and bottomed at 80.84% in Q4 2022.
  • A 5-year average of 18.91% and a median of 9.98% in 2025 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2022 — Net Margin surged 20589 bps — and 2025, when it sank 5605 bps.
  • Cresco Labs' Net Margin stood at 80.84% in 2022, then surged by 102 bps to 1.4% in 2023, then surged by 130 bps to 3.22% in 2024, then sank by 1739 bps to 52.83% in 2025, then soared by 83 bps to 8.77% in 2026.
  • Business Quant data shows CRLBF's Net Margin at 8.77% in Q1 2026, 52.83% in Q4 2025, and 10.48% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Cresco Labs 254.96 Mn 99.57 Mn 75.45 Mn -8.77%

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.77%
Dec 31, 2025 -52.83%
Sep 30, 2025 -10.48%
Jun 30, 2025 -9.98%
Mar 31, 2025 -8.71%
Dec 31, 2024 3.22%
Sep 30, 2024 -5.86%
Jun 30, 2024 -29.54%
Mar 31, 2024 -2.99%
Dec 31, 2023 1.40%
Sep 30, 2023 -60.65%
Jun 30, 2023 -18.46%
Mar 31, 2023 -13.41%
Dec 31, 2022 -80.84%
Sep 30, 2022 -4.65%
Jun 30, 2022 -6.21%
Mar 31, 2022 -12.77%
Dec 31, 2021 -286.73%
Sep 30, 2021 -128.28%
Jun 30, 2021 -2.30%